Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor.

Eitemau Tebyg

• Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor.
  gan: Markowitz, M, et al.
  Cyhoeddwyd: (1995)
• Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease.
  gan: Kaplan, A H, et al.
  Cyhoeddwyd: (1994)
• Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease.
  gan: Kempf, D J, et al.
  Cyhoeddwyd: (1991)
• In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 1 Variants with Increased Resistance to ABT-378, a Novel Protease Inhibitor
  gan: Carrillo, Alejandro, et al.
  Cyhoeddwyd: (1998)
• Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.
  gan: Kempf, D J, et al.
  Cyhoeddwyd: (1997)